Shreevikaa Kannan: The challenges of CAR-T therapies in T-cell lymphoma by Jasmine Zain

Shreevikaa Kannan, Head of TSMU academic department, shared on LinkedIn:

“Don’t miss the opportunity to hear from Dr. Jasmine Zain as she delves into the challenges of CAR-T therapies in T-cell lymphoma.
Gain valuable insights into the complexities and innovations shaping this transformative treatment.
Join MedNews Week for an engaging session that promises to expand your understanding of CAR-T therapies on September 7, 2024, 4:00 pm EDT.”

Additional information.
Source: Shreevikaa Kannan/LinkedIn